India carbamazepine
market is expected to grow at a steady rate during the forecast period. The
India carbamazepine market is driven by use of these drugs for the treatment of
epilepsy and neuropathic pain. Carbamazepine are available as chewable tablet,
suspension, tablet, extended release tablet, and extended release capsule. In
addition to this, upsurge in the demand for carbamazepine for treating numerous
types of seizures and bipolar disorders is expected to rev up the market growth
through FY2026. Additionally, supportive government policies and improving
healthcare infrastructure are some other reasons that are expected to create
lucrative opportunities for the market growth over the next few years.
The India carbamazepine
market is segmented based on route of administration, source, form,
distribution channel, application, end user, company and region. Based on
source, the market can be split into in-house and contract manufacturing
organizations. Out of which, the in-house segment dominated the market until
2017 owing to in house production preference by the major market players. The
contract manufacturing organizations segment is expected to witness significant
growth during the forecast period on account of increased outsourcing
activities by the major companies in order to focus on their R&D activity
and expansion plans. Additionally, contract manufacturing organizations offer competitive
pricing and can provide bulk orders in lesser duration.
The major players
operating in the India carbamazepine market are Taj Pharmaceuticals Ltd, Jubilant
Pharma Ltd., Novartis India Ltd., Abbott India Ltd., Psychotropics India
Limited, Anuja Healthcare Limited, Taro Pharmaceuticals India Pvt. Ltd., Teva
Pharmaceuticals Industries Ltd., Biomed Pharmaceuticals Pvt. Ltd., Sun
Pharmaceuticals Industries Limited and others. Major companies are developing
advanced technologies, receiving approvals from regulatory bodies and launching new
products in order to stay competitive in the market. Other competitive
strategies include product launches, mergers & acquisitions and new product
developments.
Years
considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year:
FY2021
Forecast Period:
FY2022–FY2026
Objective of the Study:
- To analyze and estimate the market size of
India carbamazepine market from FY2016 to FY2019.
- To estimate and forecast the market size of
India carbamazepine market from FY2020 to FY2026 and growth rate until
FY2026.
- To classify and forecast India carbamazepine market
based on route of administration, source, form, distribution channel,
application, end user, company and regional distribution.
- To identify dominant region or segment in the
India carbamazepine market.
- To identify drivers and challenges for India carbamazepine
market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in
India carbamazepine market.
- To identify and analyze the profile of leading
players operating in India carbamazepine market.
- To identify key sustainable strategies adopted
by market players in India carbamazepine market.
Click here to download the sample
TechSci Research performed
both primary as well as exhaustive secondary research for this study.
Initially, TechSci Research sourced a list of manufacturers across the globe.
Subsequently, TechSci Research conducted primary research surveys with the identified
companies. While interviewing, the respondents were also enquired about their
competitors. Through this technique, TechSci Research could include the
manufacturers which could not be identified due to the limitations of secondary
research. TechSci Research analyzed the manufacturers, distribution channels
and presence of all major players across the globe.
TechSci Research calculated the market size of India carbamazepine market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also
studied by TechSci Research.
Key Target Audience:
- Carbamazepine manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to carbamazepine
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides allowing
them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this
report, India carbamazepine market has been segmented into following
categories, in addition to the industry trends which have also been detailed
below:
- India Carbamazepine Market, By Route of
Administration:
- India Carbamazepine Market, By Source:
- In-House
- Contract Manufacturing Organizations
- India Carbamazepine Market, By Form:
- Tablet
- Capsule
- Injection
- Syrup
- Others
- India Carbamazepine Market, By Distribution
Channel:
- India Carbamazepine Market, By Application:
- Epilepsy
- Neuropathic Pain
- Seizure
- Bipolar Disorder
- Trigeminal Neuralgia
- Others
- India Carbamazepine Market, By End User:
- India Carbamazepine Market, By Region:
Competitive Landscape
Company Profiles: Detailed analysis of the
major companies present in India carbamazepine market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India carbamazepine market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]